ascendis

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma Shares Jump While Competitor Misses Results

Ascendis Pharma A/S (NASDAQ: ASND) shares jumped over 40% in premarket on Friday following the news that its competitor, Versartis Inc. (NASDAQ: VSAR) late-stage clinical trial missed its primary endpoint. Versartis shares plummeted down over 86 per..